Flecacor™

For more information about CMIs and how to read them, please visit How to read Consumer Medicine Information (CMI).

1. Supraventricular arrhythmias: a) due to pre-excitation syndromes, e.g. Wolff-Parkinson-White and Lown-Ganong-Levine syndromes. b) due to dual AV nodal pathways in patients with debilitating symptoms. c) Paroxysmal atrial fibrillation/flutter (PAF) associated with disabling symptoms. Although FLECACOR may be effective in supraventricular arrhythmias in patients with structural heart disease, its use has been associated with life threatening and occasionally fatal ventricular arrhythmias. In these patients, particularly in the presence of impaired left ventricular function, FLECACOR should be used with extreme caution, preferably after other anti-arrhythmic drugs have been tried or considered inappropriate. Use of FLECACOR in chronic atrial fibrillation has not been adequately studied and is not recommended. 2. Life threatening ventricular arrhythmias not controlled by other drugs. Intravenous flecainide(available as Tambocor injection) is indicated when rapid control or short-term prophylaxis of the above arrhythmias is the main clinical requirement. All use of the injection should be in hospitals only. FLECACOR tablets are used for continuous maintenance of normal rhythm following initial oral or intravenous therapy or conversion by other means. Prescribers should also consult the "Precautions" section of this Product Information.

Source: ARTG

• Shelf lifetime is 3 Years
• Store below 30 degrees Celsius

Source: ARTG

Non-composite pack

This medicine contains one component only.

Component

• Tablet, uncoated
• Oral
• A white, biconvex round tablet being approximately 8.5mm in diameter, marked 'TR' breakline '100' on one side and '3M' on the other.

Source: ARTG

These medicine packs are available from a pharmacist and requires a prescription. It is Schedule 4: Prescription Only Medicine.?What is the medicines and poisons schedule?

All medicines and poisons in Australia are categorised by how they are made available to the public. Medicines with a low safety risk are usually less tightly controlled than medicines with a higher safety risk. This system is called ‘scheduling’. You can read more about the scheduling of medicines as well as the different scheduling categories on our Scheduling of medicines and poisons information page.

• 60

Source: ARTG

This medicine is not listed on the Pharmaceutical Benefits Scheme (PBS). Talk to your pharmacist about how much it will cost.

Source: PBS

For the active ingredient: flecainide

You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

Source: AHT

If you experience a side effect from this medicine, tell your doctor or pharmacist. Or report it directly to the TGA (Therapeutic Goods Administration).

You can report side effects to your doctor, or directly at Report an adverse event or safety problem (Opens in new tab)

Source: ARTG

Healthdirect medicines information is not intended for use in an emergency. If you are suffering an acute illness, overdose, or emergency condition, call triple zero (000) and ask for an ambulance.

Reasonable care has been taken to provide accurate information at the time of creation. This information is not intended to substitute medical advice, diagnosis or treatment and should not be exclusively relied on to manage or diagnose a medical condition. Please refer to our terms and conditions (Opens in new tab).